Log in · Sign up
AbbVie Inc. (ABBV) reported Capex of USD 587,000,000 for the period from 2026-01-01 to 2026-06-30 in its 10-Q (accession 0001551152-26-000026, filed 2026-08-03).
| Period | Value | Verify |
|---|---|---|
| 2026-01-01 ~ 2026-06-30 | $587,000,000 | EDGAR ↗ |
| 2025-06-30 (comparative) | $504,000,000 | EDGAR ↗ |
Company AbbVie Inc. · CIK 1551152
Form 10-Q · Accession 0001551152-26-000026 · Filed 2026-08-03
XBRL tag us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · unit USD · duration
Values are read directly from the inline XBRL the company filed with EDGAR. The EDGAR links above point to the exact figure inside the filing document. No ratios or interpretation are added here.
AbbVie Inc. (ABBV) reported Capex of USD 587,000,000 for the period from 2026-01-01 to 2026-06-30 in its 10-Q (accession 0001551152-26-000026, filed 2026-08-03).
— aiSwingX, https://aiswingx.com/n/0001551152-26-000026/PaymentsToAcquirePropertyPlantAndEquipment
JSON: /api/v1/facts/0001551152-26-000026/PaymentsToAcquirePropertyPlantAndEquipment